Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc. (REGN) — Form 144: Proposed sale of shares
AI-generated summary
Officer ANDREW J MURPHY proposed to sell 5,011 shares of Common stock with an aggregate market value of $4,773,278.16 through UBS Financial Services, Inc., following an acquisition of the shares through an exercise of stock options on November 16, 2026. The proposed sale is associated with a trading plan adopted on May 7, 2026.
Key facts
- Seller
- MURPHY ANDREW J
- Relationship
- Officer
- Shares to sell
- 5,011
- Market value
- $4,773,278.16
- Approximate sale date
- Nov 17, 2026
- Broker
- UBS Financial Services, Inc.
- Acquired
- Nov 16, 2026 · Exercise of Stock Options
Rule 10b5-1 plan · adopted May 7, 2026
More REGN filings
- S-8
Filed Nov 19, 2026
- 4
Filed Nov 18, 2026
- 4
Filed Nov 18, 2026
- 4
Filed Nov 18, 2026
- 144
Filed Nov 17, 2026
- 144
Filed Nov 16, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.